ABSI
Biotechnology · Healthcare
CTO
Equibles does not estimate personal net worth.
Get an email with a short summary when Absci Corp publishes a filing, an earnings call transcript or a press release.
Get ABSI alertsMatthew Weinstock is recorded as CTO at Absci Corp (ABSI). The newest filing on record that lists Matthew Weinstock as CTO at Absci Corp (ABSI) is dated April 26, 2022. The proxy statement of Absci Corp reports total compensation of $2,324,195 for Matthew Weinstock in fiscal 2021, including a base salary of $379,886. Disclosed compensation is on record for 2 fiscal years. Matthew Weinstock has spoken on 1 earnings call across 1 company, most recently for Absci Corp on November 9, 2021. Absci Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Absci Corp includes Sean McClain (CEO and Board Member), Zachariah Jonasson (CFO), Zachariah Jonasson, Ph.D. (CFO) and 7 others.
“I'm going to highlight four main areas of R&D investment in Absci and the accomplishments those investments have led to, along with how it's driving business opportunities.”
Start not stated–present
Last confirmed April 26, 2022
ABSI
Biotechnology · Healthcare
CTO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Absci Corp (ABSI) | Chief Technology Officer | $379,886 | $2,324,195 |
| 2020 | Absci Corp (ABSI) | Chief Technology Officer | $151,583 | $453,459 |